Recombinant Human TNFRSF9 Protein (Leu24-His183), C-6×His-tagged
Product Description
Cat
IMP-9951
Official Symbol
TNFRSF9
Product Overview
Recombinant human 4-1BB/TNFRSF9 protein (Leu24-His183) with a C-terminal 6×His tag was expressed in Chinese Hamster Ovary cell line.
Description
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB.
Expression System
CHO
Species
Human
Tag
C-6×His
Predicted N Terminal
Leu24
Form
Lyophilized from a 0.2 μm filtered solution in PBS.
Molecular Mass
Predicted Molecular Mass: 18 kDa
SDS-PAGE: 25-38 kDa, reducing conditions
Protein length
Leu24-His183
Bio-activity
Measured by its binding ability in a functional ELISA. When Recombinant Human 4-1BB/TNFRSF9/CD137 is immobilized at 50 ng/mL, 100 μL/well, the concentration of Recombinant Human 4-1BB Ligand/TNFSF9 that produces 50% of the optimal binding response is approximately 2.5-12.5 ng/mL.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 500 μg/mL in PBS.
Bioactivity-ELISA 1
Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Human 4-1BB/TNFRSF9/CD137 is immobilized at 50 ng/mL, 100 μL/well, the concentration of Recombinant Human 4-1BB Ligand/TNFSF9 that produces 50% of the optimal binding response is approximately 2.5-12.5 ng/mL.

Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info